Showing results (791-800 of 994) with videos related to
Sort By:
Pageof 100
Journal of Pharmaceutical Policy and Practice|June 23, 2018
Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industriesRamesh Sharma Poudel, Shakti Shrestha, Santosh Thapa, et al.Journal of Pharmaceutical Policy and Practice|November 29, 2016
Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesisShahrzad Salmasi, Long Chiau Ming, Tahir Mehmood KhanJournal of Pharmaceutical Policy and Practice|August 13, 2020
To evaluate the impact of opening up ownership of pharmacies in South AfricaRajatheran Moodley, Fatima SulemanJournal of Pharmaceutical Policy and Practice|July 30, 2020
Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan; a record reviewMuhammad Atif, Razia Fatima, Nafees Ahmad, et al.Journal of Pharmaceutical Policy and Practice|March 28, 2015
What variables should be considered in allocating Primary health care Pharmaceutical budgets to districts in Uganda?Paschal N Mujasi, Jaume Puig-JunoyJournal of Pharmaceutical Policy and Practice|March 28, 2015
Patient access schemes in Asia-pacific markets: current experience and future potentialChristine Y Lu, Caitlin Lupton, Shana Rakowsky, et al.Journal of Pharmaceutical Policy and Practice|April 4, 2015
Tuberculosis deaths: are we measuring accurately?Muhammad Atif, Syed Azhar Syed Sulaiman, Asrul Akmal Shafie, et al.Journal of Pharmaceutical Policy and Practice|May 1, 2023
Patients' views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative studyAbdulrhman Al Rowily, Mohamed A Baraka, Mohammed H Abutaleb, et al.Journal of Pharmaceutical Policy and Practice|May 10, 2023
Antibiotic utilization pattern in treatment of acute diarrheal diseases: the case of Hiwot Fana Specialized University Hospital, Harar, EthiopiaBeyene Dereje, Shegaye Yibabie, Zenebe Keno, et al.Journal of Pharmaceutical Policy and Practice|May 2, 2023
Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunitiesWarren A Kaplan, Carlotta M Cellini, Kwesi Eghan, et al.Pageof 100